Kolexia
Hubert Dominique Médecine interne
Hubert Dominique
Médecine interne
Hôpital Cochin
Paris, France
112 Activités
15 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Infections à Pseudomonas Grippe humaine Aspergillose bronchopulmonaire allergique Diabète Céphalée Hémoptysie Insuffisance respiratoire

Collaborateurs

Voir plus
Burgel Pierre-Regis
Burgel Pierre-Regis
Hôpital Cochin, Paris, France
Kanaan Reem
Kanaan Reem
Hôpital Cochin, Paris, France
Dusser Daniel
Dusser Daniel
Hôpital Cochin, Paris, France
Munck Anne
Munck Anne
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Vertex
5 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.
Molecular therapy : the journal of the American Society of Gene Therapy   14 janvier 2023
MUCOKIDS: Experiences, Expectations and Needs of Children Whose Parents Have Cystic Fibrosis - Exploratory Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   28 octobre 2022
P-554 Impact of genotype and phenotype on ICSI outcomes of cystic fibrosis (CF) men patients: a cohort study about 107 ICSI from 1999 to 2019
38th Hybrid Annual Meeting of the European Society of Human Reproduction and Embryology   29 juin 2022
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   24 décembre 2021
Correction to: Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.
Pulmonary therapy   24 novembre 2021
Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.
Pulmonary therapy   08 juin 2021
MucoPar: Expectations and Needs of Patients With Cystic Fibrosis Becoming Parents - Exploratory Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   16 avril 2021
"Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspective.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   27 février 2021
Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
Biochimica et biophysica acta. Molecular basis of disease   11 novembre 2020
S1P serum concentration is increased in CFTR-F508DEL patients: A novel biomarker of cystic fibrosis related bone disease
Bone reports   01 octobre 2020